Architectural interventions to mitigate the spread of SARS-CoV-2 in emergency departments.

Agent-based modelling Architectural interventions Infection Prevention and Control Nosocomial Infections SARS-CoV-2

Journal

The Journal of hospital infection
ISSN: 1532-2939
Titre abrégé: J Hosp Infect
Pays: England
ID NLM: 8007166

Informations de publication

Date de publication:
15 Jun 2024
Historique:
received: 05 02 2024
revised: 06 05 2024
accepted: 20 05 2024
medline: 18 6 2024
pubmed: 18 6 2024
entrez: 17 6 2024
Statut: aheadofprint

Résumé

Emergency departments (EDs) are a critical entry gate for infectious agents into hospitals. In this interdisciplinary study, we explore how infection prevention and control (IPC) architectural interventions mitigate the spread of emerging respiratory pathogens using the example of SARS-CoV-2 in a prototypical ED. Using an agent-based approach, we integrate data on patients' and healthcare workers' (HCWs) routines and the architectural characteristics of key ED areas. We estimate the number of transmissions in the ED by modelling the interactions between and among patients and HCWs. Architectural interventions are guided towards the gradual separation of pathogen carriers, compliance with a minimum interpersonal distance, and deconcentrating airborne pathogens (higher air exchange rates (AERs)). Interventions are epidemiologically evaluated for their mitigation effects on diverse endpoints. Simulation results indicate that higher AERs in the ED (compared to baseline) may provide a moderate level of infection mitigation (incidence rate ratio (IRR) of 0.95 (95% CI 0.93 - 0.98)) while the overall burden decreases more when separating rooms in examination areas (IRR of 0.78 (95% CI 0.76 - 0.81)) or when increasing the size of the ED base (IRR of 0.79 (95% CI 0.78 - 0.81)). The reduction in SARS-CoV-2-associated nosocomial transmissions is largest when combining architectural interventions (IRR of 0.61 (95% CI 0.59 - 0.63)). These modelling results highlight the importance of IPC architectural interventions; they can be devised independently of profound knowledge of an emerging pathogen, focusing on technical, constructive, and functional components. These results may inform public health decision-makers and hospital architects on how IPC architectural interventions can be optimally used in healthcare premises.

Identifiants

pubmed: 38885930
pii: S0195-6701(24)00204-4
doi: 10.1016/j.jhin.2024.05.019
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Competing Interest The authors declare no conflict of interest.

Auteurs

Gustavo Hernandez-Mejia (G)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany. Electronic address: mejia@uni-muenster.de.

Simone Scheithauer (S)

Institute of Infection Control and Infectious Diseases, University Medical Center Göttingen, University of Göttingen, Germany.

Sabine Blaschke (S)

Central Emergency Department, University Medical Center Göttingen, Göttingen, Germany.

Nataliya Kucheryava (N)

Institute of Infection Control and Infectious Diseases, University Medical Center Göttingen, University of Göttingen, Germany.

Kjell Schwarz (K)

Institute of Infection Control and Infectious Diseases, University Medical Center Göttingen, University of Göttingen, Germany.

Julia Moellmann (J)

Institute of Construction Design, Industrial and Health Care Building, Technical University of Braunschweig, Braunschweig, Germany.

Damilola Victoria Tomori (DV)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Antonia Bartz (A)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Veronika K Jaeger (VK)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Berit Lange (B)

Department of Epidemiology, Helmholtz Centre for Infection Research, Braunschweig, Germany.

Alexander Kuhlmann (A)

Faculty of Medicine, Martin Luther University Halle-Wittenberg, Halle (Saale), Germany; Biomedical Research in End-Stage and Obstructive Lung Disease Hannover (BREATH), German Center for Lung Research (DZL), Hanover, Germany.

Jan Holzhausen (J)

Institute of Construction Design, Industrial and Health Care Building, Technical University of Braunschweig, Braunschweig, Germany.

André Karch (A)

Institute of Epidemiology and Social Medicine, University of Münster, Münster, Germany.

Classifications MeSH